维普期刊资源整合服务平台（V6.5）

25篇 您的检索式：作者名="Merchant NB"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	TaN0 rectal cancer:re- suits following sharp mesorectal excision and no adjuvant therapy 显示文摘	Merchant NB Guillem JG Paty PB	1999	J Gastrointest Surg1999，3，6：	1
2	Extremity and trunk desomid tumors:a multifactorial analysis of outcome显示文摘	Merchant NB Lewis JJ Woodruff JM	1999	Cancer1999，86，10：	1
3	Laparoscopic evaluation in pancreatic cancer显示文摘	Merchant NB Conlon KC	1998	Semin Surg Oncol1998，15，3：	1
4	Hepatic resection using in- termittent vascular inflow occlusion and low central venous pres- sure anesthesia improves morbidity and mortality 显示文摘	Chen H Merchant NB Didolkar MS	2000	J Gastroin- test Surg2000，4，2：	1
5	TACE/ADAM17:a component of the epidermal growth factor receptor axis and a promising therapeutic target in colorectal cancer显示文摘	Merchant NB Voskresenskyl Rogers CM	2008	Clin Cancer Res2008，14，4：	1
6	Src-mediated regulation of E--cad- herin and EMT in pancreatic cancer显示文摘	Nagathihalli NS Merchant NB	2012	Front Biosci2012，1，17：	1
7	Adjuvant chemoradiation therapy for pancreatic adenocarcinoma:who really benefits?显示文摘	Merchant NB Rymer J Koehler EA	2009	J Am Coll Surg2009，208，5：	1
8	Emerging targetsin pancreatic cancer: epithelial-mesenchymal transition andcancer stem cells显示文摘	Castellanos JA Merchant NB Nagathihalli NS	2013	Onco Targets Ther2013，6，：	1
9	Laparoscopic evaluation in pancreatic cancer显示文摘	Merchant NB Conlon KC	1998	Semin Surg Oncol1998，15，3：	1
10	TACE/ ADAM17: a component of the epidermal growth factor receptor axis and a promising therapeutic target in colorectal cancer显示文摘	Merchant NB Voskresensky I Rogers CM	2008	Clin Cancer Res2008，14，4：	1
11	T3N0 rectal cancer:results following sharp mesorectal excision and no adjuvant therapy显示文摘	Merchant NB Guillem JG Paty PB		0，，6：	1
12	Extremity and trunk desmoid tumors:A multifactorial analysis of outcome显示文摘	Merchant NB Lewis JJ Woodruff JM	1999	Cancer1999，86，：	1
13	The role of calcitoningene-related peptide and nitric in gastric mucosal hyperemia and protection显示文摘	Merchant NB Goodman J Dempsey DT	1995	J Surg Res1995，58，3：	1
14	Combined blockade of Src kinase and epidermal growth factor receptor with gemcitabine overcomes STAT3-mediated resistance of inhibition of pancreatic tumor growth 显示文摘	Nagaraj NS Washington MK Merchant NB	2011	Clin Cancer Res2011，17，3：	1
15	Hepatic resection using intermittent vascular inflow occlusion and low central venous pressure anesthesia improves morbidity and mortality显示文摘	Chen H Merchant NB Didolkar MS	2000	J Gastrointest Surg2000，4，2：	1
16	Extremity and trunk desmoid tumors: A muhifactorial analysis of outcome 显示文摘	Merchant NB Lewis J J Woodruff JM	1999	Cancer1999，86，10：	1
17	Hepatic resection using intermittent vascular inflow occlusion and low central venous pressure anesthesia improves morbidity and mortality显示文摘	Chen H Merchant NB Didolkar MS	2000	J Gastrointest Surg2000，4，2：	1
18	Emerging targets in pancreatic cancer: epithelial-mesenchymal transition and cancer stem cells 显示文摘	CasteUanos JA Merchant NB Nagathihalli NS	2013	Onto Targets Ther2013，6，：	1
19	TACE/ADAM- 17: a component of the epidermal growth factor receptor axis and a promising therapeutic target in colorectal cancer 显示文摘	Merchant NB Voskresensky I Rogers CM	2008	J Clin Cancer Res2008，14，4：	1
20	Hepatic resection using intermittent vascular inflow occlusion and low central venous pressure anesthesia improves morbidity and mortality 显示文摘	CHEN H MERCHANT NB DODOLKAR MS	2000	J Gastrointest Surg2000，4，2：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示